Axsome Therapeutics Inc (NAS:AXSM)
$ 90.94 -1.47 (-1.59%) Market Cap: 4.37 Bil Enterprise Value: 4.31 Bil PE Ratio: 0 PB Ratio: 42.30 GF Score: 39/100

Q2 2022 Axsome Therapeutics Inc Earnings Call Transcript

Aug 09, 2022 / 12:00PM GMT
Release Date Price: $44.76 (+3.35%)
Operator

Good morning, and welcome to the Axsome Therapeutics conference call. I would now like to turn the conference over to your host, Mark Jacobson, Chief Operating Officer at Axsome Therapeutics. Mark, please go ahead.

Mark L. Jacobson
Axsome Therapeutics, Inc. - COO & Secretary

Thank you, operator. Good morning, and thank you all for joining us on today's conference call. This morning, we issued our earnings press release, providing a corporate update and details of the company's financial results for the second quarter of 2022. And the release crossed the wire a short time ago and is available on our website at axsome.com.

During today's call, we will be making certain forward-looking statements. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our investigational agents; our clinical and non-clinical plans; our plans to present or report additional data; the anticipated conduct and the source of future clinical trials; regulatory plans; future research and development plans

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot